Plasma histamine levels (H) during adjunctive H1-receptor antagonist treatment with loratadine in patients with active inflammatory bowel disease (IBD).
Raithel
M
M
Functional Tissue Diagnostics, Department Medicine I, University Erlangen, Erlangen, Germany. martin.raithel@uk-erlangen.de
Nägel
A
A
Zopf
Y
Y
deRossi
Th
T
Stengel
Ch
Ch
Hagel
A
A
Kressel
J
J
Hahn
E G
EG
Konturek
P
P
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000097:blood / Q000188:drug therapy; D003424:Crohn Disease / Q000097:blood / Q000188:drug therapy; D006632:Histamine / Q000097:blood*; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000097:blood* / Q000188:drug therapy*; D017336:Loratadine / Q000627:therapeutic use*; D019804:Mesalamine / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D006634:Histamine H1 Antagonists; D019804:Mesalamine; D017336:Loratadine; D006632:Histamine; D011239:Prednisolone